• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MDT PUERTO RICO OPERATIONS CO SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MDT PUERTO RICO OPERATIONS CO SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE Back to Search Results
Model Number 8637-20
Device Problem Human-Device Interface Problem (2949)
Patient Problems Low Blood Pressure/ Hypotension (1914); Overdose (1988)
Event Date 07/01/2020
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Information was received from a foreign healthcare professional (hcp) via a manufacturer representative regarding a patient receiving intrathecal baclofen 2000 mcg/ml at 216.1 mcg/day via an implantable pump.It was reported that the patient showed overdose symptoms.The physician operated emergency procedures on the patient.Additionally, the patient wanted to stop the pump.The device manufacturer technical services department provided the manufacturer representative with a pump stop code.It was further reported that the patient responded positively to the retrieval of cerebrospinal fluid (csf) from the catheter access port (cap) operated by the physician.For this reason, the physician decided not to stop the pump, but rather give a priming bolus and continue to give the patient the intrathecal baclofen therapy.It seemed that during the cap procedure, some blood was retrieved as well.However, the physician suspected that the blood was coming from the surrounding tissue and not from the csf, as the healthcare professional (hcp) had to do multiple punctures before getting into the cap.The patient was not reported to having been involved in an accident or trauma.It was noted that on (b)(6) 2020 the patient had a pump refill, suggesting that the overdose could be due to a pocket refill.However, this could not be confirmed so far as the pump reservoir had not been emptied yet.During the interrogation of the pump, no error codes or alarms were reported by the physician programmer.The elective replacement indicator (eri) was calculated to occur in 6 months.Information regarding the pump implant date was not available.It was unknown if any environmental, external or patient factors might have led or contributed to the event.It was unknown if any [additional] diagnostics/troubleshooting were performed.It was unknown if any [additional] actions/interventions were taken.Surgical intervention did not occur and was not planned.The issue was resolved.The patient's status was alive - no injury.Information regarding the patient¿s age, weight, medical history, and other medications was unavailable.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received from a foreign manufacturer representative on 2020-jul-28.It was reported that the cause of the difficulty accessing the cap and requiring multiple punctures was unknown.The patient's overdose symptoms occurred the next morning after the refill.The physician determined that the symptoms were unlikely to be caused by a pocket fill after physically inspecting the pocket.No imaging was used to confirm the needle position.It was unknown if the fluid removed from the pump had the expected appearance.It was confirmed that the volume injected into the pump was not excessively different from the expected volume.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received in response to a request for follow-up.The additional information indicated that the specific o verdose symptoms that the patient experienced after the refill was a drop in blood pressure.It was clarified that the patient did not show any overdose symptom at the time of retrieving the csf sample procedure.It was further described that the csf sample retrieved during the reported emergency procedure performed was sent to a laboratory to determine if there was any infection.It was also confirmed that there was no change in programming made [other than the reservoir volume] at the refill prior to the overdose event.However, the cause of the overdose symptoms was not determined and the patient had recovered.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNCHROMED II
Type of Device
PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
Manufacturer (Section D)
MDT PUERTO RICO OPERATIONS CO
rd 31 km 24 hm 4
juncos PR 00777
MDR Report Key10286535
MDR Text Key199221311
Report Number3004209178-2020-12351
Device Sequence Number1
Product Code LKK
UDI-Device Identifier00643169100831
UDI-Public00643169100831
Combination Product (y/n)N
PMA/PMN Number
P860004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 08/17/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/16/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/28/2015
Device Model Number8637-20
Device Catalogue Number8637-20
Was Device Available for Evaluation? No
Date Manufacturer Received08/06/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-